Meena Sakharkar
Meena Sakharkar
College of Pharmacy and Nutrition, University of Saskatchewan
Verified email at - Homepage
TitleCited byYear
Distributions of exons and introns in the human genome
MK Sakharkar, VTK Chow, P Kangueane
In silico biology 4 (4), 387-393, 2004
Significance of HbA1c test in diagnosis and prognosis of diabetic patients
SI Sherwani, HA Khan, A Ekhzaimy, A Masood, MK Sakharkar
Biomarker insights 11, BMI. S38440, 2016
A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa
KR Sakharkar, MK Sakharkar, VTK Chow
In silico biology 4 (3), 355-360, 2004
Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro
P Jayaraman, MK Sakharkar, CS Lim, TH Tang, KR Sakharkar
International journal of biological sciences 6 (6), 556, 2010
Biodegradation of low density polythene (LDPE) by Pseudomonas species
BM Kyaw, R Champakalakshmi, MK Sakharkar, CS Lim, KR Sakharkar
Indian journal of microbiology 52 (3), 411-419, 2012
Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa
S Tin, KR Sakharkar, CS Lim, MK Sakharkar
International journal of biological sciences 5 (2), 153, 2009
ExInt: an exon intron database
M Sakharkar, F Passetti, JE de Souza, M Long, SJ de Souza
Nucleic acids research 30 (1), 191-194, 2002
An analysis on gene architecture in human and mouse genomes
MK Sakharkar, BS Perumal, KR Sakharkar, P Kangueane
In silico biology 5 (4), 347-365, 2005
Differential genome analyses of metabolic enzymes in Pseudomonas aeruginosa for drug target identification
D Perumal, CS Lim, KR Sakharkar, MK Sakharkar
In silico biology 7 (4, 5), 453-465, 2007
Genome SEGE: a database for'intronless' genes in eukaryotic genomes
MK Sakharkar, P Kangueane
Bmc Bioinformatics 5 (1), 67, 2004
Druggability of human disease genes
MK Sakharkar, KR Sakharkar, S Pervaiz
The international journal of biochemistry & cell biology 39 (6), 1156-1164, 2007
Computational identification and experimental validation of PPRE motifs in NHE1 and MnSOD genes of human
G Venkatachalam, AP Kumar, LS Yue, S Pervaiz, MV Clement, ...
BMC genomics 10 (S3), S5, 2009
In vitro combinations of antibiotics and phytochemicals against Pseudomonas aeruginosa
MK Sakharkar, P Jayaraman, WM Soe, VTK Chow, LC Sing, ...
Journal of Microbiology, Immunology and Infection 42 (5), 364-370, 2009
SEGE: A database on ‘intron less/single exonic’genes from eukaryotes
MK Sakharkar, P Kangueane, DA Petrov, AS Kolaskar, S Subbiah
Bioinformatics 18 (9), 1266-1267, 2002
Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains
VJ Lee, JK Tay, MIC Chen, MC Phoon, ML Xie, Y Wu, CXX Lee, J Yap, ...
Vaccine 28 (42), 6852-6857, 2010
Comparative study of overlapping genes in bacteria, with special reference to Rickettsia prowazekii and Rickettsia conorii
KR Sakharkar, MK Sakharkar, C Verma, VTK Chow
International journal of systematic and evolutionary microbiology 55 (3 …, 2005
A framework to sub-type HLA supertypes
P Kangueane, MK Sakharkar, G Rajaseger, S Bolisetty, B Sivasekari, ...
Front Biosci 10 (1-3), 879-886, 2005
Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer
S Thangavel, T Yoshitomi, MK Sakharkar, Y Nagasaki
Journal of Controlled Release 209, 110-119, 2015
Comparative study for the effects of variable nutrient conditions on the biodegradation of microcystin-LR and concurrent dynamics in microcystin-degrading gene abundance
J Li, K Shimizu, MK Sakharkar, M Utsumi, Z Zhang, N Sugiura
Bioresource technology 102 (20), 9509-9517, 2011
Targetability of human disease genes
MK Sakharkar, KR Sakharkar
Current drug discovery technologies 4 (1), 48-58, 2007
The system can't perform the operation now. Try again later.
Articles 1–20